| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1995 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2009 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2020 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2002 | 2018 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2002 | 2010 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2007 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 1996 | 2007 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | |||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2016 | |||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
hepatitis A virus cellular receptor 2 | 0.450 | 0.808 | 3.9E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 |